News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

A Randomized Phase II Study of Intrabucally Administered Electromagnetic Fields versus Placebo for Patients with Child-Pugh A or B Advanced Hepatocellular Carcinoma

Study Status:

Not yet active

Contact Information:

(956) 362-2394

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary goal of this study is to gather efficacy data concerning overall survival with electromagnetic fields when compared to a placebo amplitude-modulated radiofrequency electromagnetic field device in subjects who have failed or are intolerant to at least two previous systemic therapies.

Information: 

Principal Investigator
Dr. Lee C. Drinkard
Co-PI
Edgar Lopez Pacheco
Sponsor
Wake Forest Baptist Comprehensive Cancer Center
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram